Agronomics

Agronomics operates as an investment company specializing in cellular agriculture and alternative protein technologies. The company focuses on ventures that produce food products and materials through cell cultures and microbial fermentation rather than conventional animal agriculture. This investment approach targets companies developing methods to grow animal proteins and create sustainable materials using biological processes.

The portfolio encompasses over 20 companies across several technology categories. Cultivated meat ventures grow animal tissue directly from cells in controlled environments. Precision fermentation companies use engineered microorganisms to produce dairy proteins, fats and other animal-derived ingredients. The portfolio also includes companies developing sustainable alternatives to materials like palm oil and leather through cellular agriculture methods.

The investment thesis centers on technologies that can produce animal proteins and materials with reduced environmental resource requirements compared to conventional agriculture. These methods typically require less land and water per unit of protein produced and generate lower greenhouse gas emissions than traditional livestock farming. The approach also addresses animal welfare considerations by reducing dependence on animal farming systems.

Agronomics operates as a publicly listed investment vehicle, providing shareholders with diversified exposure to the cellular agriculture sector. The portfolio structure distributes capital across multiple companies at various development stages, from early research to commercial scaling. This approach spreads risk across different technologies and business models within the alternative protein ecosystem.